Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy
Autore:
Schneider, J; Gonzalez-Roces, S; Pollan, M; Lucas, R; Tejerina, A; Martin, M; Alba, A;
Indirizzi:
Fdn Tejerina, Ctr Patol Marna, E-28003 Madrid, Spain Fdn Tejerina MadridSpain E-28003 Ctr Patol Marna, E-28003 Madrid, Spain Univ Pais Vasco, E-48080 Bilbao, Spain Univ Pais Vasco Bilbao Spain E-48080 v Pais Vasco, E-48080 Bilbao, Spain Inst Estud Celulares & Mol, Lugo, Spain Inst Estud Celulares & Mol Lugo Spain stud Celulares & Mol, Lugo, Spain Inst Nacl Epidemiol, Madrid, Spain Inst Nacl Epidemiol Madrid SpainInst Nacl Epidemiol, Madrid, Spain Univ Complutense Madrid, Madrid, Spain Univ Complutense Madrid Madrid Spain Complutense Madrid, Madrid, Spain
Titolo Testata:
BREAST CANCER RESEARCH
fascicolo: 3, volume: 3, anno: 2001,
pagine: 183 - 191
SICI:
1465-542X(2001)3:3<183:EOLAMI>2.0.ZU;2-Z
Fonte:
ISI
Lingua:
ENG
Soggetto:
P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; OVARIAN-CARCINOMA; TUMOR RESPONSE; PROTEIN LRP;
Keywords:
axillary nodes; chemotherapy; LRP; multidrug resistant; neoadjuvant;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
19
Recensione:
Indirizzi per estratti:
Indirizzo: Schneider, J Fdn Tejerina, Ctr Patol Marna, Calle Jose Abascal 40, E-28003Madrid, Spain Fdn Tejerina Calle Jose Abascal 40 Madrid Spain E-28003 pain
Citazione:
J. Schneider et al., "Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy", BREAST CA R, 3(3), 2001, pp. 183-191

Abstract

Background: Axillary node status after induction chemotherapy for locally advanced breast cancer has been shown on multivariate analysis to be an independent predictor of relapse. However, it has been postulated that responders to induction chemotherapy with a clinically negative axilla could be spared the burden of lymphadenectomy, because most of them will not show histological nodal invasion. P-glycoprotein expression in the rescue mastectomyspecimen has finally been identified as a significant predictor of patientsurvival. Materials and methods: We studied the expression of the genes encoding multidrug resistance associated protein (MDR1) and lung cancer associated resistance protein (LRP) in formalin-fixed, paraffin-embedded tumor samples from 52 patients treated for locally advanced breast cancer by means of induction chemotherapy followed by rescue mastectomy. P-glycoprotein expression was assessed by means of immunohistochemistry before treatment in 23 cases, and by means of reverse-transcriptase-mediated polymerase chain reaction (RT-PCR) after treatment in 46 (6 failed). LRP expression was detected by means of immunohistochemistry, with the LRP-56 monoclonal antibody, in 31 cases before treatment. Immunohistochemistry for detecting the expression of c-erb-B2, p53, Ki67, estrogen receptor and progesterone receptor are routinely performed in our laboratory in every case, and the results obtained were included in the study. All patients had received between two and six cyclesof standard 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy, with two exceptions [one patient received four cycles of a docetaxel-adriamycin combination, and the other four cycles of standard cyclophosphamide-methotrexate-5-fluorouracil (CMF) polychemotherapy]. Response was assessed in accordance with the Response Evaluation Criteria In Solid Tumors (RECIST), By these, 2 patients achieved a complete clinical response, 37 a partial response, and the remaining 13 showed stable disease. This makes a total clinical response rate of 75.0%. None achieved a complete pathological response. Results: MDR1 mRNA expression detected by RT-PCR was associated with the presence of invaded axillary nodes at surgery in 18/22 cases (81.8%), compared with 13/24 (54.2%) in the group with undetectable MDR1 expression. This difference was statistically significant (P < 0.05). LRP expression in morethan 20% of tumor cells before any treatment was associated with axillary nodal metastasis after chemotherapy and rescue mastectomy in 17/23 cases, compared with 3/8 in nonexpressors. Again, this difference was highly significant (P< 0.01). LRP expression before treatment and MDR1 mRNA expression after treatment were significantly interrelated (P< 0.001), which might reflect the presence of chemoresistant clones liable to metastasize to the regional nodes. Persistence of previously detected MDR1-positivity after treatment (7/9 compared with 0/2 cases) was significantly associated with axillary node metastasis (P< 0.05). Finally, in a logistic regression multivariatemodel, histology other than ductal, a Ki67 labeling index of at least 20% and the combination of LRP and MDR1 positivity emerged as independent predictors of axillary node invasion at the time of rescue mastectomy. Conclusion: The expression of different genes involved in resistance to chemotherapy, both before and after treatment with neoadjuvant, is associatedwith the presence of axillary node invasion at rescue surgery in locally advanced breast cancer. This might reflect the presence of intrinsically resistant clones before any form of therapy, which persist after it, and couldbe helpful both for prognosis and for the choice of individual treatment.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/07/20 alle ore 00:48:02